Among participants with MS which represents a progressive neurological illness we observed an increase in the values from baseline to follow-up of with mean circulating GDF15 of 677 pg/ml (95% CI 580–776) and 729 pg/ml (95% CI 619–839) (p = 0.01). This evidence concerns the gene GDF15 and myeloid sarcoma.